Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in CADL — Candel Therapeutics, Inc.

CIK 936944 BOSTON, MA
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$525,135
+$309,981 QoQ
Shares Held
50,984
+16.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#53
of 138 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 33% Shared 0% None 67%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. CADL ranks #42 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,729 $21,224,776
2 INCY
Incyte Corp
 168,818 $19,137,208
3 JAZZ
Jazz Pharmaceuticals plc
 59,492 $14,335,787
4 REGN
Regeneron Pharmaceuticals, Inc.
 18,953 $11,817,953
5 LGND
Ligand Pharmaceuticals Inc
 17,562 $5,551,172
6 ACAD
Acadia Pharmaceuticals Inc
 167,893 $4,247,692
7 ALNY
Alnylam Pharmaceuticals, Inc.
 13,634 $4,104,243
8 INVA
Innoviva, Inc.
 165,115 $3,749,761

All Filings in CADL

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $525,135 50,984
2026-03-31 $215,154 43,909
2025-12-31 $211,982 37,519